RCRr Chetty

Rr Chetty

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rr Chetty has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Electrocardiogram (ECG) Diagnosis of Left Ventricular Hypertrophy and its Associations in Patients Living with Diabetes

    by Rushern R. Chetty, Somasundram Pillay

    Background: Macrovascular complications of diabetes mellitus (DM) include cardiac manifestations such as left ventricular hypertrophy (LVH), which can increase the risk of heart failure and death. Objectives: To determine associations between LVH and other variables in patients living with DM (PLWD). Methods: A retrospective study over 1 year was conducted on patients who attended the DM clinic at Edendale Hospital in South Africa. Electrocardiographs (ECGs) and standardised data sheets were analysed. The Sokolov–Lyon, Cornell and Romhilt–Estes methods were utilised for diagnosing LVH on ECGs. Results: There were 609 PLWD included in the study, with 80 PLWD (13.1%) having LVH (LVH+), whereas 529 PLWD (86.9%) had no LVH (LVH−). The Sokolov–Lyon method proved to be the best method of diagnosing LVH based on ECG (100% of patients diagnosed), with an ‘R wave in Augmented Vector Left (AVL) ≥11 mm’ being the best approach for determining LVH. LVH + patients were significantly younger than LVH − patients (27.22 years vs. 58.98 years, P < 0.001) and had lower systolic blood pressure (SBP) (118.62 mmHg vs. 139.77 mmHg, P < 0.001). Type 1 DM (DM1+) comprised the majority (77.5%) of LVH + patients. LVH + patients had significantly better high-density lipoproteins (1.36 mmol/L vs. 1.25 mmol/L, P = 0.024) and triglycerides (1.40 mmol/L vs. 1.85 mmol/L, P = 0.010) than LVH − patients. Conclusion: LVH was seen more frequently in younger patients who often had DM1+, lower SBP, higher HDL, and lower triglycerides. Most cases of LVH were diagnosed using the Sokolov–Lyon method. LVH should be screened for frequently in PLWD, irrespective of whether patients are hypertensive or not, and this should be done at all ages.

  • Open Access

    Age and diabetes control in an HIV-endemic country: is there an association?

    by Rr Chetty, S Pillay

    The prevalence of diabetes mellitus (DM) in South Africa (SA) is 12.80% and is rising, while that of HIV infection remains the highest globally (13%). Literature varies on the associations between ...

  • Open Access

    The relationship between age and glycaemic control in patients living with diabetes mellitus in the context of HIV infection: a scoping review

    by Rr Chetty, S Pillay

    Patients living in low- and middle-income countries (LMIC) comprise approximately 79% of the global number of adult patients living with diabetes (PLWD). In addition, South Africa (SA), a LMIC, has...


  • Open Access

    Adult height and diabetes control: is there an association?

    by Rr Chetty, S Pillay

    Obesity is commonly associated with diabetes mellitus (DM). The most frequent anthropometric index utilised to assess obesity is the body mass index (BMI), which uses height and weight as variables, but eliminates height as an independent analytical variable. Currently there are no data available on the relationship between adult height and glycaemic control in patients living with diabetes (PLWD) within the context of HIV infection. This study aimed to determine an association between final adult height and glycaemic control in an HIV endemic area. Standardised clinic sheets were used from the DM clinic at Edendale Hospital, Pietermaritzburg, South Africa, from January 1, 2019 to December 31, 2019. Statistical analysis was done. This study had 957 PLWD. In the height categories of < 1.40 m, 1.40–1.49 m, 1.50–1.59 m, 1.60–1.69 m, 1.70–1.79 m, 1.80–1.89 m and ≥ 1.90 m, there were 11, 60, 321, 343, 121, 26 and 2 patients respectively (with 73 patients having no height recorded). Taller patients had smaller waist circumferences and had poorer glycaemic control. In the lowest vs. highest height (< 1.40 m vs ≥ 1.90 m) categories, the HbA1c values were 8.49% vs. 12.45%, respectively, p = 0.019. Height had a strong positive association with diastolic blood pressure (DBP) (p = 0.001). Those PLWD in the 1.80–1.89 m height cohort had higher triglyceride levels and lower high-density lipoprotein (HDL) levels when compared with the other height categories. Shorter PLWD with uncontrolled glycaemic control had significantly elevated systolic blood pressure. Gender and HIV infection had a non-significant role on height categories in PLWD. Taller height categories had poorer glycaemic control. Increasing height was strongly associated with increasing DBP. A higher DBP and triglyceride level with lower HDL level places these PLWD in a higher cardiovascular risk category. Strong emphasis needs to be placed on the monitoring of lipids and blood pressure in PLWD, this more especially in taller patients.

  • Open Access

    Glycaemic control and family history of diabetes mellitus: is it all in the genes?

    by Rr Chetty, S Pillay

    Background: Type 2 diabetes mellitus (T2DM) is a familial condition with a strong genetic component. International studies have highlighted associations between a positive family history of diabetes (FHD) and poorer glycaemic control. No current data are available on this association within the context of HIV. Objectives: To determine a relationship between FHD and glycaemic control in patients living with DM (PLWD) in an HIV endemic area. Methods: Standardised clinic sheets were used from the DM clinic at Edendale Hospital, Pietermaritzburg, South Africa, from January 1, 2019 to December 31, 2019. Statistical analysis was done. Results: This study had 957 patients living with diabetes (PLWD); 498 (52.2%) had a positive FHD while 456 (47.8%) had no FHD. There were 146 (15.3%) HIV-infected patients; with 84 (57.5%) on a fixed dose combination (FDC) of anti-retroviral treatment (ART). Patients aged between 18 and 30 with a maternal FHD had significantly higher mean HbA1c levels than those without a maternal FHD (HbA1c: 10.80% vs. 9.72%, p = 0.025). Patients living with type 1 DM (PLWT1DM) in the HIV-uninfected cohort had significantly higher HbA1c levels than patients living with type 2 DM (PLWT2DM) (10.38% vs. 9.46%, p = 0.002). HIV-infected PLWD (PLWDH) on a FDC with a positive FHD had significantly higher HbA1c levels than those without a FHD (9.52% vs. 8.52%, p = 0.04). PLWDH with a positive maternal FHD on an FDC had increased HbA1c levels (9.81% vs. 8.55%, p = 0.009). Conclusion: Genes significantly affect glycaemic control among PLWD. PLWT1DM and PLWDH with a positive FHD (especially a maternal FHD) should be regarded as being in a higher risk category requiring more intensive lifestyle and therapeutic intervention to achieve optimal diabetes control. Our study suggests that a positive FHD affects glycaemia in PLWT1DM as significantly, if not more, than in PLWT2DM and recommends screening for a FHD to be incorporated in the comprehensive management of DM.